Does LAMIVUDINE Cause Lipodystrophy acquired? 383 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 383 reports of Lipodystrophy acquired have been filed in association with LAMIVUDINE (Lamivudine and Zidovudine). This represents 2.3% of all adverse event reports for LAMIVUDINE.
383
Reports of Lipodystrophy acquired with LAMIVUDINE
2.3%
of all LAMIVUDINE reports
1
Deaths
64
Hospitalizations
How Dangerous Is Lipodystrophy acquired From LAMIVUDINE?
Of the 383 reports, 1 (0.3%) resulted in death, 64 (16.7%) required hospitalization, and 1 (0.3%) were considered life-threatening.
Is Lipodystrophy acquired Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LAMIVUDINE. However, 383 reports have been filed with the FAERS database.
What Other Side Effects Does LAMIVUDINE Cause?
Foetal exposure during pregnancy (1,905)
Virologic failure (1,894)
Drug resistance (1,889)
Pathogen resistance (1,733)
Viral mutation identified (1,631)
Treatment failure (933)
Exposure during pregnancy (846)
Drug interaction (744)
Drug ineffective (726)
Immune reconstitution inflammatory syndrome (625)
What Other Drugs Cause Lipodystrophy acquired?
ZIDOVUDINE (313)
NEVIRAPINE (288)
STAVUDINE (283)
RITONAVIR (254)
LOPINAVIR\RITONAVIR (230)
DIDANOSINE (216)
TENOFOVIR DISOPROXIL (205)
EFAVIRENZ (203)
INDINAVIR (195)
ABACAVIR (194)
Which LAMIVUDINE Alternatives Have Lower Lipodystrophy acquired Risk?
LAMIVUDINE vs LAMIVUDINE\NEVIRAPINE\ZIDOVUDINE
LAMIVUDINE vs LAMIVUDINE\TENOFOVIR
LAMIVUDINE vs LAMIVUDINE\TENOFOVIR DISOPROXIL
LAMIVUDINE vs LAMIVUDINE\ZIDOVUDINE
LAMIVUDINE vs LAMOTRIGINE